Private Market View

Claris Bio

Drug Discovery · Jersey City, NJ · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
$163.4M
Total raised
$153.6M
Last round
Later Stage VC (Series A)
Jan 2024
What is Claris Bio worth?
$163.4Mlast known valuation

Claris Bio last raised $54.5M in its Later Stage VC (Series A) (Jan 2024).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 5 names
  • ·Watchlist + deal alerts for Claris Bio
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Jan 2024Later Stage VC (Series A)$54.5M

How Claris Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Claris Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Claris Bio worth?
Claris Bio's last known valuation is $163.4M.
How much has Claris Bio raised?
Claris Bio has raised $153.6M in total funding across 1 recorded rounds.
When did Claris Bio last raise?
Claris Bio last raised in Jan 2024 (Later Stage VC (Series A)), raising $54.5M.